Mesonephroma

This is a very rare type of tumor, usually found in the ovary. It's a small growth made of cells that are leftover from early development. It's not cancer, but it's a type of tumor that needs to be watched.

Condition

What people with Mesonephroma report

Every report comes from a Lived member, sent anonymously.

Have you had Salpingo-oophorectomy for Mesonephroma?

NameHow it went

About Mesonephroma

What It Is

Mesonephroma is an older medical name for a rare cancer that most often starts in the ovary. Doctors once believed these tumors grew from leftover embryonic kidney tissue (the mesonephros), which is where the name comes from. That idea turned out to be wrong, and the label is now largely historical: a current pathology report will usually name one of the two quite different tumors it used to cover. The first is clear cell carcinoma, a type of ovarian cancer that develops in adults. It was named because, under the microscope, its cells resemble those of a common kidney cancer. The second is the yolk sac tumor (also called endodermal sinus tumor), a germ cell cancer, meaning it starts in the cells that would normally develop into eggs or sperm. It occurs mainly in children, teenagers and young women, and it can also arise in the testicle. Both are malignant, meaning they can grow into nearby tissue and spread. Because the two behave and are treated so differently, the specific diagnosis matters far more than the old name.

Causes & Risk Factors

For most people, no single cause can be identified, and the two tumors have different risk patterns. Clear cell carcinoma is strongly linked to endometriosis, a condition in which tissue similar to the lining of the uterus grows outside it. Endometriosis is found in more than half of people diagnosed with this cancer. This is an association: having endometriosis does not mean someone will develop it. Clear cell carcinoma is also much more common in Asia, where it makes up about 20 to 25 percent of ovarian cancers of its broad type (epithelial ovarian cancers), compared with roughly 5 to 13 percent in Western countries. Why yolk sac tumors develop is not well understood. They arise from germ cells, and they are most often found around puberty and in young adulthood.

How It's Diagnosed

Both tumors usually come to attention as a mass in the pelvis or abdomen. Symptoms can include pain, swelling or a feeling of pressure in the belly or pelvis, feeling full quickly or needing to urinate often, although an early tumor may cause none. Imaging, typically ultrasound followed by a CT (computed tomography) or MRI (magnetic resonance imaging) scan, shows the size and character of the mass and whether it has spread. Clear cell carcinoma often appears as a large, mostly fluid-filled growth on one ovary with solid areas inside it. Blood tests help narrow the possibilities. Yolk sac tumors release a protein called alpha-fetoprotein (AFP), so a raised AFP level alongside an ovarian mass in a young person points toward a germ cell tumor. The same test is later repeated to show whether treatment is working. The diagnosis is confirmed only when a pathologist examines the tumor tissue under a microscope, usually after it has been removed. The same operation is used for staging: the surgeon checks the abdomen, takes tissue samples and fluid washings, and looks for spread. The stage, from I (confined to the ovary) to IV (spread to distant organs such as the liver or lungs), guides what treatment comes next.

Treatment Options

Surgery is the starting point for both tumors, but what follows differs considerably. Yolk sac tumors usually respond very well to treatment. In young people who want to keep the ability to have children, surgeons can often remove only the affected ovary and its fallopian tube (a unilateral salpingo-oophorectomy), leaving the uterus and the other ovary in place. Most patients then receive a combination of three chemotherapy drugs known as BEP (bleomycin, etoposide and cisplatin), which kill rapidly dividing cancer cells. This combination cures most people with these tumors, including many whose cancer has spread beyond the ovary. When a stage I tumor has been completely removed, some patients, particularly young children, can be watched closely with AFP tests and scans instead of receiving chemotherapy straight away. The trade-offs of chemotherapy are side effects during treatment and possible lasting effects, such as hearing loss, kidney problems and reduced fertility, which the care team watches for. For clear cell carcinoma, surgery aims to remove all visible cancer and to stage it accurately. When the cancer is confined to the ovary, experts disagree about who benefits from chemotherapy afterward: for the earliest stages, pooled studies have not shown that it improves survival, while platinum-based chemotherapy is generally recommended for higher-risk early disease. For cancer that has spread or come back, clear cell carcinoma often resists the standard chemotherapy that works well for more common ovarian cancers. That is one reason clinical trials of other approaches are worth discussing, especially at advanced stages or after a recurrence.

What to Expect

Outlook depends much more on which tumor is present, and how far it has spread, than on the old name. Ovarian germ cell tumors, including yolk sac tumors, are usually cured when found and treated early, and fertility-sparing surgery is designed to preserve the chance of a future pregnancy. After treatment, follow-up includes regular visits, AFP blood tests and scans, because a rising AFP level can be an early sign that the tumor has returned. People treated with chemotherapy as children or young adults benefit from long-term checks for late effects such as hearing and kidney changes. Clear cell carcinoma found while still confined to the ovary has a favorable outlook: in pooled studies, about 86 percent of people with stage I disease were alive five years later. Outcomes are considerably worse when the cancer has spread or returns, largely because it tends to resist chemotherapy. Follow-up after treatment involves regular examinations and imaging, and a recurrence is often treated within a clinical trial or with newer drug combinations. Because both tumors are rare, it can take extra effort to find specialists, information and other people with the same diagnosis.

When to Seek Help

Arrange a medical visit for pain, swelling or pressure in the abdomen or pelvis that persists, a lump you can feel, or feeling full very quickly. In a child or teenager, a lump in the belly or abdominal pain that does not settle also deserves assessment. After treatment, tell the care team about new or returning symptoms rather than waiting for the next scheduled visit. Clear cell carcinoma carries an unusually high risk of blood clots, affecting roughly one in five people with this cancer. Contact the care team right away for a leg that becomes swollen, tender or painful, or for shortness of breath or pain when breathing, which can mean a clot has traveled to the lungs. Severe difficulty breathing needs emergency care.

Questions to Ask Your Doctor

  1. 1.Does my pathology report describe a clear cell carcinoma or a yolk sac tumor, and what stage is it?
  2. 2.Is fertility-sparing surgery an option for me, and how would treatment affect my chances of a future pregnancy?
  3. 3.Would chemotherapy after surgery add a meaningful benefit at my stage, and what side effects should I expect?
  4. 4.How often will I need blood tests and scans after treatment, and what results would suggest the cancer has returned?
  5. 5.Does this team see many patients with this rare tumor, and is there a clinical trial I should consider?

Last reviewed • Oct 2026

Educational content, not medical advice.